Nautilus, Inc. (NYSE:NLS) Receives Consensus Recommendation of “Hold” from Brokerages

Share on StockTwits

Shares of Nautilus, Inc. (NYSE:NLS) have received a consensus rating of “Hold” from the ten brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $6.43.

NLS has been the subject of a number of research reports. ValuEngine raised Nautilus from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd. Imperial Capital lowered shares of Nautilus from an “outperform” rating to an “outperform” rating and decreased their price target for the company from $4.50 to $2.00 in a research note on Monday, November 11th. Finally, Zacks Investment Research downgraded shares of Nautilus from a “hold” rating to a “sell” rating in a report on Wednesday, November 13th.

Shares of NLS stock traded up $0.21 on Friday, reaching $1.64. 25,948 shares of the company were exchanged, compared to its average volume of 388,483. The company has a market cap of $42.81 million, a price-to-earnings ratio of 3.22 and a beta of 0.89. The company has a 50-day moving average of $1.51 and a 200-day moving average of $1.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.82 and a quick ratio of 0.86. Nautilus has a one year low of $1.20 and a one year high of $13.28.

Nautilus (NYSE:NLS) last posted its quarterly earnings results on Thursday, November 7th. The specialty retailer reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.17). Nautilus had a negative return on equity of 17.57% and a negative net margin of 30.19%. The firm had revenue of $61.71 million for the quarter, compared to analyst estimates of $78.86 million. As a group, sell-side analysts predict that Nautilus will post -0.92 EPS for the current year.

Several hedge funds have recently bought and sold shares of NLS. Millennium Management LLC lifted its position in shares of Nautilus by 90.6% during the third quarter. Millennium Management LLC now owns 1,241,629 shares of the specialty retailer’s stock valued at $1,676,000 after purchasing an additional 590,187 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Nautilus in the 3rd quarter worth approximately $70,000. Russell Investments Group Ltd. boosted its stake in shares of Nautilus by 92.7% in the 3rd quarter. Russell Investments Group Ltd. now owns 118,415 shares of the specialty retailer’s stock worth $160,000 after buying an additional 56,975 shares during the last quarter. Skylands Capital LLC grew its holdings in shares of Nautilus by 56.3% in the third quarter. Skylands Capital LLC now owns 509,480 shares of the specialty retailer’s stock valued at $688,000 after acquiring an additional 183,600 shares in the last quarter. Finally, Royal Bank of Canada grew its holdings in shares of Nautilus by 58.4% in the second quarter. Royal Bank of Canada now owns 26,500 shares of the specialty retailer’s stock valued at $58,000 after acquiring an additional 9,770 shares in the last quarter. Institutional investors own 61.88% of the company’s stock.

About Nautilus

Nautilus, Inc, a consumer fitness products company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer and commercial use in the United States, Canada, and internationally. The company operates in two segments, Direct and Retail. It offers specialized cardio products, treadmills, ellipticals, bike products, strength products, home gyms, dumbbells, and weight benches primarily under the Nautilus, Bowflex, Octane Fitness, Schwinn, and Universal brands.

See Also: What is the LIBOR?

Analyst Recommendations for Nautilus (NYSE:NLS)

Receive News & Ratings for Nautilus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nautilus and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.